Physician profile
Anna Strokina
NPI 1760452726
$1,864.81
in general payments reported to CMS, 2019-2025
18 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $467 · 2020: $393 · 2021: $639 · 2022: $221 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $145.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $320.62 | 2019-2022 | |
| Amarin Pharma, INC. | $229.36 | 2019-2022 | |
| Allergan, INC. | $161.04 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $145.98 | 2021-2022 | |
| Hologic Sales and Service, LLC | $145.27 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Takeda Pharmaceuticals U.S.A., INC. | $141.77 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $108.25 | 2021-2022 | |
| Ironwood Pharmaceuticals, INC | $93.83 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $93.19 | 2020-2022 | |
| Endo Pharmaceuticals INC. | $92.77 | 2019-2022 | |
| Vivus LLC | $58.95 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $58.42 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $57.61 | 2020 | |
| Arbor Pharmaceuticals, INC. | $49.18 | 2019-2021 | |
| Lilly USA, LLC | $46.97 | 2019-2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $23.38 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $21.56 | 2021 | |
| Scilex Pharmaceuticals INC. | $16.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Strokina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.